• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FORD模型与其他可用模型在间质性肺疾病患者肺动脉高压无创预测中的性能比较

Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease.

作者信息

Kim Ho Cheol, Chandel Abhimanyu, King Christopher S, Kim Min Jee, Shawabkeh Malek, Arunachalam Ambalavanan, Tomic Rade, Nathan Steven D

机构信息

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA, 22042, USA.

出版信息

Lung. 2025 Jan 22;203(1):27. doi: 10.1007/s00408-024-00783-2.

DOI:10.1007/s00408-024-00783-2
PMID:39841267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11754375/
Abstract

PURPOSE

Pulmonary hypertension (PH) is associated with morbidity and mortality in patients with interstitial lung disease (ILD). Several prediction models have been proposed to predict PH in ILD patients. We sought to discern how previously described prediction models perform in predicting PH in patients with ILD.

METHODS

Patients with ILD who completed a baseline right heart catheterization, from Inova Fairfax Hospital, Northwestern Memorial Hospital, and Asan Medical Center in Korea were enrolled. The performance of various prediction models (FORD model, the FORD calculator, the PH-ILD Detection tool, and the mean pulmonary artery pressure prediction model) were assessed using receiver operating characteristic (ROC) curves and area under the receiver operating characteristic curve (AUROC). There were four definitions of pulmonary hypertension against which the models were evaluated.

RESULTS

There were a total of 192 patients with ILD, of whom 32.8% (n = 63/192) met the modified 5th world symposium on PH definition of precapillary PH. Among the models assessed, the FORD calculator had an AUROC (0.733) that was marginally highest. Subgroup analysis revealed that the FORD index had the highest AUROC (0.817) in patients with idiopathic pulmonary fibrosis, while the FORD calculator had the highest AUROC (0.751) in patients with non-IPF ILD.

CONCLUSION

The FORD model can be used to predict group 3 PH in both IPF patients and non-IPF ILD patients. It could serve as a tool for ILD patient selection for right heart catheterization as well as an enrichment tool for clinical trials targeting the pulmonary vasculature.

摘要

目的

肺动脉高压(PH)与间质性肺疾病(ILD)患者的发病率和死亡率相关。已经提出了几种预测模型来预测ILD患者的PH。我们试图了解先前描述的预测模型在预测ILD患者的PH方面表现如何。

方法

纳入了来自韩国峨山医学中心、弗吉尼亚州费尔法克斯英诺瓦医院和西北纪念医院完成基线右心导管检查的ILD患者。使用受试者工作特征(ROC)曲线和受试者工作特征曲线下面积(AUROC)评估各种预测模型(FORD模型、FORD计算器、PH-ILD检测工具和平均肺动脉压预测模型)的性能。针对四种肺动脉高压定义对模型进行了评估。

结果

共有192例ILD患者,其中32.8%(n = 63/192)符合第五届世界肺动脉高压研讨会修订的毛细血管前PH定义。在评估的模型中,FORD计算器的AUROC(0.733)略高。亚组分析显示,FORD指数在特发性肺纤维化患者中的AUROC最高(0.817),而FORD计算器在非IPF-ILD患者中的AUROC最高(0.751)。

结论

FORD模型可用于预测IPF患者和非IPF-ILD患者的3组PH。它可以作为ILD患者选择进行右心导管检查的工具,以及针对肺血管系统的临床试验的富集工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/11754375/556f0895e46e/408_2024_783_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/11754375/5bb02ea05e23/408_2024_783_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/11754375/556f0895e46e/408_2024_783_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/11754375/5bb02ea05e23/408_2024_783_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/11754375/556f0895e46e/408_2024_783_Fig2_HTML.jpg

相似文献

1
Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease.FORD模型与其他可用模型在间质性肺疾病患者肺动脉高压无创预测中的性能比较
Lung. 2025 Jan 22;203(1):27. doi: 10.1007/s00408-024-00783-2.
2
Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.特发性肺纤维化患者肺高血压无创预测工具的建立和验证:模型 FORD 的演进。
J Heart Lung Transplant. 2024 Apr;43(4):547-553. doi: 10.1016/j.healun.2023.11.005. Epub 2023 Nov 17.
3
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压与系统性硬化症相关肺动脉高压患者治疗后血流动力学反应及结局比较:特发性肺纤维化相关肺动脉高压预后因素研究数据。
Arthritis Rheumatol. 2021 Feb;73(2):295-304. doi: 10.1002/art.41512. Epub 2020 Dec 29.
4
Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.接受磷酸二酯酶-5抑制剂治疗的间质性肺疾病患者肺动脉高压的血流动力学变化
Respirology. 2014 Jul;19(5):700-6. doi: 10.1111/resp.12294. Epub 2014 Apr 3.
5
Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.合并和不合并间质性肺疾病的系统性硬化症中重度肺动脉高压的患病率及特征
J Rheumatol. 2007 May;34(5):1005-11. Epub 2007 Apr 15.
6
Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.晚期肺部疾病中的肺动脉高压:超声心动图作为肺移植患者评估的重要组成部分。
Clin Respir J. 2018 Mar;12(3):930-938. doi: 10.1111/crj.12608. Epub 2017 Jan 12.
7
Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease.心血管磁共振成像评估的右心室功能在间质性肺疾病患者中的预后价值
J Cardiovasc Magn Reson. 2015 Feb 11;17(1):10. doi: 10.1186/s12968-015-0113-5.
8
Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.肺毛细血管后肺动脉高压对间质性肺疾病死亡率的影响。
Respir Investig. 2021 May;59(3):342-349. doi: 10.1016/j.resinv.2020.12.010. Epub 2021 Feb 10.
9
Sjögren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease.干燥综合征与肺动脉高压:探索与间质性肺疾病的复杂联系。
Int J Cardiol. 2025 Jul 1;430:133185. doi: 10.1016/j.ijcard.2025.133185. Epub 2025 Mar 22.
10
Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.中国间质性肺疾病相关肺动脉高压的临床和血流动力学特征
Clin Respir J. 2018 Mar;12(3):915-921. doi: 10.1111/crj.12604. Epub 2017 Jan 6.

引用本文的文献

1
Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey.医生对间质性肺疾病中肺动脉高压的看法:一项基于病例的调查结果
BMC Pulm Med. 2025 May 10;25(1):231. doi: 10.1186/s12890-025-03693-y.

本文引用的文献

1
Definition, classification and diagnosis of pulmonary hypertension.肺动脉高压的定义、分类和诊断。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01324-2024. Print 2024 Oct.
2
Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.特发性肺纤维化患者肺高血压无创预测工具的建立和验证:模型 FORD 的演进。
J Heart Lung Transplant. 2024 Apr;43(4):547-553. doi: 10.1016/j.healun.2023.11.005. Epub 2023 Nov 17.
3
The PH-ILD Detection tool: External validation and use in patients with ILD.
PH-ILD检测工具:外部验证及在ILD患者中的应用
Pulm Circ. 2023 Aug 8;13(3):e12273. doi: 10.1002/pul2.12273. eCollection 2023 Jul.
4
Noninvasive determinants of pulmonary hypertension in interstitial lung disease.间质性肺疾病中肺动脉高压的无创性决定因素
Pulm Circ. 2023 Feb 19;13(1):e12197. doi: 10.1002/pul2.12197. eCollection 2023 Jan.
5
Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection.间质性肺疾病患者的肺动脉高压:一种早期检测工具。
Pulm Circ. 2022 Oct 1;12(4):e12141. doi: 10.1002/pul2.12141. eCollection 2022 Oct.
6
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.间质性肺疾病患者肺动脉高压的筛查策略:一项多学科德尔菲研究
Chest. 2022 Jul;162(1):145-155. doi: 10.1016/j.chest.2022.02.012. Epub 2022 Feb 15.
7
Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life.间质性肺疾病或慢性阻塞性肺疾病所致肺动脉高压:一项关于症状及其对生活质量影响的患者体验研究
Pulm Circ. 2021 Apr 1;11(2):20458940211005641. doi: 10.1177/20458940211005641. eCollection 2021 Apr-Jun.
8
External validation of prognostic models: what, why, how, when and where?预后模型的外部验证:是什么、为什么、如何、何时以及何地?
Clin Kidney J. 2020 Nov 24;14(1):49-58. doi: 10.1093/ckj/sfaa188. eCollection 2021 Jan.
9
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
10
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis.超声心动图 HRCT 评分联合评估特发性肺纤维化患者肺动脉高压的作用。
Intern Emerg Med. 2021 Jun;16(4):941-947. doi: 10.1007/s11739-020-02539-1. Epub 2020 Nov 5.